200
Participants
Start Date
May 31, 2015
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2030
Collection of data from endoscopic ultrasound or MRI/MRCP of the abdomen
Participants in this study should be undergoing pancreatic cancer screening with endoscopic ultrasound or MRI as part of their standard care. These should typically be done at least every 12 months, and the imaging tests will be ordered as routine clinical tests and will be billed to the participant's insurance. This study does not cover the costs of these screening tests, however the study will track the results of these screening tests.
Blood sample collection for research
Up to 40mL of blood may be collected for analysis at each screening examination.
RECRUITING
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Abramson Cancer Center at Penn Medicine
OTHER